Executive 1-on-1 Matchmaking
A private deal-brokering environment connecting isotope producers, bioconjugation CDMOs, and analytical platforms directly with hospital radiopharmacy department heads and oncology clinical trial PIs in Paris.
The Four-Stage Bilateral Matchmaking Protocol
Eliminating the randomness of traditional trade show halls through curated scheduling, mutual interest verification, and dedicated meeting coordination.
Clinical Profile Intake
4 weeks prior to Paris, registered commercial partners receive the verified, anonymized directory of attending hospital radiopharmacy heads, CMC directors, and trial PIs.
Priority Target Selection
Partners select their top clinical and enterprise meeting priorities. The Secretariat cross-references clinical pipeline needs to establish mutual matchmaking interest.
Pre-Scheduled Itinerary
2 weeks prior to convening, partners receive their finalized briefing schedule locked into dedicated 75-minute luncheon and afternoon networking windows without plenary conflicts.
Concierge Execution
In Paris, Secretariat concierges greet your target buyers and escort them directly into Saloon Alpha or Beta at their designated briefing time for focused 20-minute bilaterals.
Guaranteed Buyer Briefing Allocations by Tier
Contractual performance covenants govern every commercial tier, guaranteeing pre-scheduled bilateral meeting volumes with hospital and biotech buyers.
Saloon Alpha (Monopoly Suite)
Exclusive access to Saloon Alpha for all 10 bilaterals. Includes hospital radiopharmacy chairs and active Phase I–III trial PIs.
Saloon Beta (Curriculum Suite)
Dedicated briefing tables in Saloon Beta. Primary focus on biotech heads of CMC, discovery VPs, and bioconjugation leads.
Foyer Briefing Station
Assigned branded briefing station in the central foyer. Focuses on clinical trial coordinators and procurement managers.
Saloon Alpha Architecture (Lead Partners)
Configured specifically for executive procurement and clinical protocol evaluations:
- Acoustic Isolation: Sound-dampened executive boardroom layout ensuring confidentiality for clinical trial data, isotope allocation terms, and licensing discussions.
- Presentation Infrastructure: Integrated 4K display monitors, wireless projection, and dedicated high-speed encrypted Wi-Fi networks.
- Continuous Hospitality: Dedicated barista service, French pastry platters, and Champagne aperitifs during bilateral briefing intervals.
Verified Buyer Selection Criteria
Every attendee admitted into the matchmaking pool must satisfy verifiable institutional benchmarks:
- Hospital Decision Makers: Chairs or lead radiopharmacists at accredited European or international nuclear medicine centers.
- Clinical Investigators: Principal or Co-Investigators with active Phase I–III trials involving radioligands or ADCs.
- Biotech Executives: C-level officers or VPs of Chemistry, Manufacturing, and Controls (CMC) managing active therapeutic pipelines.
Initiate Matchmaking Account Profiling
Submit your commercial objectives and target buyer profiles. The Secretariat will review attendee distribution and confirm meeting allocations within 48 business hours.